PathXL today announced it will unveil a significant upgrade to its award-winning product, TissueMark®, which will now include a powerful add-on for cell counting. The formal announcement will take place at the forthcoming Global Engage Digital Pathology Congress, to be held in London on Dec 4th and 5th, where PathXL’s founder and VP for R&D, Professor Peter Hamilton, will be giving a detailed presentation.
TissueMark will now include a powerful add-on for cell counting
The tumor cell counting capability is powered by PathXL’s Tissue Recognition Engine™ and is an extension to PathXL’s current TissueMark range, designed for the rapid and automated detection and analysis of tumor tissue on digitized, H&E stained tissue samples.
“Automated tumor cell counting is one of the most sought after applications in the field of digital imaging,” said Des Speed, CEO of PathXL. “I’m proud of the work our team have done here in bringing together several different approaches to crack this problem. The new TissueMark product will prove hugely valuable to those labs that need to feed accurate tumor content information into the molecular pathology process and for those wishing to establish strong quality and audit trails”
